Search Orphan Drug Designations and Approvals
-
| Generic Name: | cintredekin besudotox (CB) |
|---|---|
| Date Designated: | 07/11/2025 |
| Orphan Designation: | treatment of malignant glioma (glioblastoma multiforme) |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Precision Neuromed 3200 Bridge Parkway Suite 202 Redwood City, California 94065 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







